Our results demonstrated that the LAT1 inhibitor nanvuranlat reduced metastatic nodule formation in metastasis mouse models, illustrating the potential of using nanvuranlat to decrease or prevent cancer metastasis. This evidence concerns the gene SLC7A5 and cancer.